Daito Pharmaceutical Co (TSE:4577) EV-to-EBIT : 11.87 (As of May. 25, 2025)

Daito Pharmaceutical Co EV-to-EBIT Chart

Daito Pharmaceutical Co Annual Data
	Trend	May15	May16	May17	May18	May19	May20	May21	May22	May23	May24
EV-to-EBIT		Get a 7-Day Free Trial					10.35	7.70	5.47	6.83	9.45

Daito Pharmaceutical Co Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
EV-to-EBIT	Get a 7-Day Free Trial															7.99	9.45	9.59	10.40	-

Competitive Comparison of Daito Pharmaceutical Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daito Pharmaceutical Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's EV-to-EBIT falls into.

Daito Pharmaceutical Co EV-to-EBIT Calculation

Daito Pharmaceutical Co's EV-to-EBIT for today is calculated as:

Daito Pharmaceutical Co's current Enterprise Value is 円39,062 Mil.
Daito Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,291 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co  (TSE:4577) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Daito Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2024 is calculated as:

Daito Pharmaceutical Co's Enterprise Value for the quarter that ended in Nov. 2024 was 円40,215 Mil.
Daito Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,291 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Daito Pharmaceutical Co Business Description